Allegro’s osteoarthritis hydrogel reduces lameness in animal study
Allegro updated this press release on April 20, 2026, to refine certain statements in accordance with regulatory guidelines Liege, Belgium – 12 […]
Category: News
Allegro to start production of osteoarthritis hydrogel device as it prepares for clinical trials
Liege, Belgium – 9 January 2026 (08:30 CET) – Allegro NV, a biomedical company developing transformative injectable, mechanically-acting devices for osteoarthritis, will […]
Allegro and American Regent sign exclusive licensing deal for Synoglide, a novel osteoarthritis device in animal health, valued at up to $35 million
Liege, Belgium and Shirley, NY – 25 November 2025 (08:30 CET) – Allegro NV, a biomedical company developing transformative nanotechnology-based devices for […]
Allegro showcases superior shock-absorbing capacity of injectable hydrogel device for osteoarthritis at CellMech
Allegro updated this press release on April 20, 2026, to refine certain statements in accordance with regulatory guidelines Liege, Belgium – 7 […]
Allegro appoints life sciences veteran as Chief Operating Officer to advance osteoarthritis treatment
Liege, Belgium – 3 September 2025 (08:30) – Allegro NV, a biomedical company developing transformative devices for degenerative joint disease, has appointed […]
Allegro secures financing for clinical trial preparations in osteoarthritis
Allegro updated this press release on April 20, 2026, to refine certain statements in accordance with regulatory guidelines Liege, Belgium – 3 […]
The Soft Touch
Allegro was featured in the Noshaq Stories this month with a full feature article in French. Read the full article below or […]
Allegro demonstrates safety profile of osteoarthritis hydrogel in data presentation at World Congress on Osteoporosis
Liege, Belgium – 11 April 2025 (17:00 CET) – Allegro NV, a biomedical company developing transformative nanotechnology-based treatments for osteoarthritis, today presented […]
Allegro’s injectable osteoarthritis device generates positive safety results in preclinical studies
Liege, Belgium – 25 March 2025 (08:30 CET) – Allegro NV, a biomedical company developing transformative nanotechnology-based devices for osteoarthritis, has found […]
Allegro reports positive safety data for its injectable osteoarthritis device in three preclinical studies
Allegro updated this press release on April 20, 2026, to refine certain statements in accordance with regulatory guidelines Liege, Belgium – 4 […]